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ABSTRACT
Bone marrow adipose tissue (BMAT) resides within the bone marrow microenvironment where its function remains poorly under-
stood. BMAT is elevated in anorexia nervosa, a disease model of chronic starvation, despite depletion of other fat depots. In addition
to BMAT, themarrowmicroenvironment also consists of osteoblast and hematopoietic progenitors. BMAT is inversely associated with
bone mineral density (BMD) in multiple populations including women with anorexia nervosa, and regulates hematopoiesis in animal
models. We hypothesized that BMAT would be associated with circulating populations of hematopoietic cells (red and white blood
cells) in humans and performed a post hoc analysis of two studies—a cross-sectional study and a longitudinal study—to investigate
this hypothesis. We studied 89 premenopausal women cross-sectionally (median age [interquartile range], 27 [24.5, 31.7] years),
including 35 with anorexia nervosa. We investigated associations between red blood cell (RBC) and white blood cell (WBC) counts
and BMAT assessed by 1H-magnetic resonance spectroscopy, BMD assessed by DXA, and bone microarchitecture assessed by HR-
pQCT. In addition, we analyzed longitudinal data in six premenopausal women with anorexia nervosa treated with transdermal estro-
gen for 6 months and measured changes in BMAT and blood cell counts during treatment. Cross-sectionally, BMAT was inversely
associated with WBC and RBC counts. In contrast, BMD and parameters of bone microarchitecture were positively associated with
WBC and RBC. In womenwith anorexia nervosa treatedwith transdermal estrogen for 6 months, decreases in BMATwere significantly
associated with increases in both RBC and hematocrit (rho = −0.83, p = 0.04 for both). In conclusion, we show that BMAT is inversely
associated with WBC and RBC in premenopausal women, and there is a potential association between longitudinal changes in BMAT
and changes in RBC. These associations warrant further study andmay provide further insight into the role and function of this under-
studied adipose depot. © 2020 American Society for Bone and Mineral Research.
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Introduction
The bone marrow consists of two types of stem cells:(i) mesenchymal stem cells, which differentiate into osteo-
blasts or adipocytes, and (ii) hematopoietic stem cells, which dif-
ferentiate into red blood cells (RBCs), white blood cells (WBCs), or
platelets. In murine models, osteoblasts are important regulators
of hematopoiesis(1) and induced osteoblast-depletion results in a
decrease in erythroid, lymphoid, and myeloid progenitors.(2) In
humans, both RBC and WBC populations are associated with
bone mineral density (BMD) and anemia has been shown to be
an independent predictor of fracture.(3) Further, low hemoglobin
levels are associated with low BMD in older adults,(4) and higher
rates of bone loss at the hip have been associated with both an
increased risk of anemia as well as low lymphocyte counts in
men 65 years or older.(5)
Bone marrow adipose tissue (BMAT), another component of
the bone marrow microenvironment, is also associated with
bone parameters in humans. BMAT is inversely associated with
BMD in populations of healthy adults(6,7) and also in a model of
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chronic starvation, anorexia nervosa.(8) Women with anorexia
nervosa have higher levels of BMAT compared to normal-weight
controls despite having significantly lower levels of subcutane-
ous and visceral adipose tissue depots.(8) Although the function
of BMAT is not currently known, the fact that this adipose tissue
depot is preserved during chronic starvation, when other fat
depots are being used as a source of energy, suggests it may
have an important role.
In murine models, granulocyte-colony stimulating factor,
which leads to an increase in circulating neutrophils, has been
associated with reductions in BMAT(9) and BMAT has also been
associated with reduced hematopoiesis.(10) Therefore, to better
understand the potential function and determinants of BMAT
in humans, we explored the association between BMAT and cells
from the hematopoietic lineage, specifically RBC and WBC
counts in premenopausal women using both cross-sectional
and longitudinal study designs. We hypothesized that BMAT




We performed post hoc analyses of two prior studies. The first
was a study investigating levels of BMAT in premenopausal
women, inclusive of women with anorexia nervosa, normal-
weight controls, and obese women.(11–14) The second study
was a longitudinal study investigating the effects of low-dose,
transdermal estrogen on BMD and BMAT in premenopausal
women with anorexia nervosa.(15) Eighty-nine premenopausal
women were studied cross-sectionally, inclusive of 35 women
with anorexia nervosa (median age [interquartile range], 26.8
[24.6, 31.0] years; range, 20.3 to 45.1 years). In addition, we stud-
ied six women with anorexia nervosa (median age [interquartile
range], 34.3 [28.5, 45.4] years; range, 25.3 to 45.5 years) longitudi-
nally for 6 months, during which time they were treated with
low-dose, transdermal estrogen (Climara Pro; Bayer Pharmaceu-
ticals, Whippany, NJ, USA) a treatment that has been associated
with a reduction in BMAT in postmenopausal and premeno-
pausal women.(15,16) This particular transdermal formulation con-
tains 0.045 mg of estradiol/day and 0.015 mg of levonorgestrel/
day, a progesterone, which is necessary for the prevention of
endometrial hyperplasia in women with an intact uterus. As
previously described,(15) this formulation was chosen because it
contains a dose of estradiol that we hypothesized would be
effective in improving BMD based on data in postmenopausal
women.(17) BMAT and/or bone parameters from a subset of sub-
jects were previously reported.(11–15,18) Hematologic data have
not been previously reported. Subjects were recruited either
through online advertisements or through referrals from local
eating disorder providers for both the cross-sectional and longi-
tudinal studies. Subjects with anorexia nervosa met Diagnostic
and Statistical Manual of Mental Disorders (DSM-5) criteria for
the disorder.(19) Subjects without anorexia nervosa had a
BMI > 18.5 kg/m2 (range, 20.8 to 41.7 kg/m2), none reported a
past or current history of an eating disorder, none were taking
medications known to affect bone mass, and all reported having
regular menstrual cycles. Participants who had abnormal thyroid
function tests or chronic diseases that affect BMD (other than
anorexia nervosa) were excluded.
Cross-sectional study
All subjects were evaluated at the Translational and Clinical
Research Center at the Massachusetts General Hospital during
two study visits: a screening visit and a baseline study visit. All
subjects had a complete blood count inclusive of RBC count,
WBC count, hemoglobin and hematocrit levels, and a platelet
count at the time of their screening visit, performed by a clinical
laboratory (LabCorp, Burlington, NC, USA). Subjects then
returned for a study visit within 3 months of their screening visit,
at which time they were weighed on an electronic scale while
wearing a hospital gown, their height was measured on a single
stadiometer as the average of three readings, and radiologic
imaging, including dual-energy X-ray absorptiometry (DXA),
1H-magnetic resonance spectroscopy (1H-MRS), and high-
resolution peripheral quantitative CT (HR-pQCT), was performed
(radiologic imaging is described below in the Radiologic Imaging
section).
Longitudinal study
All subjects were evaluated at the Translational and Clinical
Research Center at the Massachusetts General Hospital for base-
line and 6-month study visits. After the baseline visit, subjects
were started on low-dose, transdermal estrogen/progesterone
and they continued using the patch until their 6-month study
visit. At each study visit, all six subjects had a complete blood
count, inclusive of RBC count, WBC count, hemoglobin and
hematocrit levels, and a platelet count, and 1H-MRS (described
in the 1H-MRS section below) performed.
The study complied with the Health Insurance Portability and
Accountability Act guidelines and was approved by the Partners
Institutional Review Board. All subjects provided written
informed consent prior to the initiation of study procedures.
Radiologic imaging
DXA
All subjects underwent DXA to measure areal BMD of the
posterior-anterior (PA) lumbar spine (L1–L4), lateral spine (L2–L4),
left total hip, left femoral neck, and total body using a Hologic Dis-
covery A densitometer (Hologic Inc., Bedford, MA, USA). Coeffi-
cients of variation (CVs) for the measurement of BMD by DXA
have been reported to be less than 2.2%.(20)
High resolution peripheral quantitative computed tomography
(HR-pQCT)
HR-pQCT (isotropic voxel size of 82 μm3) was performed in the
nondominant distal radius and tibia (Xtreme CT; Scanco Medical
AG, Brüttisellen, Switzerland) as previously described.(21) As pre-
viously described,(22,23) linear micro-finite element analysis of
HR-pQCT images was subsequently performed in order to esti-
mate the biomechanical properties of the distal radius and the
distal tibia under uniaxial compression loading. Outcomes from
linear micro-finite element analysis included both compressive
stiffness (kN/mm) and failure load (kN). The biomechanical prop-
erties estimated from micro-finite element analysis are strongly
correlated with those measured through the ex vivo testing of
elderly human cadaveric radii.(24)
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1H-MRS
The Metabolic Imaging Core of the Nutrition and Obesity
Research Center at Harvard performed 1H-MRS as previously
described.(8) Briefly, lipid content of the L4 vertebra, proximal
femoral epiphysis, metaphysis, and mid-diaphysis was measured
using 1H-MRS (Siemens Trio, 3T; Siemens Medical Systems,
Erlangen, Germany). This was performed by placing a voxel mea-
suring 15 × 15 × 15 mm3 (3.4 mL) within the body of the L4 ver-
tebra and then using point-resolved spatially localized
spectroscopy (PRESS) pulse sequence without water suppression
(parameters: echo time [TE] of 30 ms, repetition time [TR] of
3000 ms, eight acquisitions, 1024 data points, and receiver band-
width of 2000 Hz), single-voxel 1H-MRS data were obtained. Sim-
ilarly, in the femur, single-voxel 1H-MRS, using the same non-
water suppressed PRESS pulse sequence, was performed in the
femur after a 12 × 12 × 12 mm3 (1.7 mL) voxel was placed in
the proximal femoral epiphysis and repeated after voxel place-
ment in the mid-diaphysis and the intertrochanteric region of
the femoral metaphysis. Automated procedures were used to
optimize gradient shimming and transmit and receive gain. We
have reported that the CV for marrow fat quantification,
obtained by scanning five subjects two times each, is 3%.(25)
1H-MRS data were fitted using LCModel software (version
6.1-4A; Stephen Provencher, Oakville, ON, Canada). Metabolite
quantification was obtained using eddy current correction and
water scaling after data were transferred to a Linux workstation.
A fitting algorithm customized for analysis of bone marrow was
used to provide estimates for all of the lipid signals combined
(0.9, 1.3, and 2.3 ppm). The lipid estimates for bone marrow
using LCModel software were automatically scaled to an unsup-
pressed water peak (4.7 ppm) and results were expressed as a
lipid to water ratio.
Statistical analysis
JMP Pro 13.0 (SAS Institute, Inc., Cary, NC, USA) software was
used to perform statistical analyses. The Student’s t test was used
to compare means and standard deviations (SDs) unless data
were not normally distributed, in which case the Wilcoxon test
was used to compare median (interquartile range). Univariate
associations were assessed using Pearson correlation coeffi-
cients (R), or if data were non-normally distributed, Spearman
coefficients (rho). Spearman coefficients were calculated in the
analysis of the longitudinal data, given the small sample size
(n = 6). A p value <0.05 was used to indicate significance.
Results
Clinical characteristics
Clinical characteristics of the study subjects, including BMD and
bone microarchitecture data, are listed in Table 1. Subjects were
all premenopausal. Subjects in the cross-sectional study were a
median of 27 years of age (median age [interquartile range],
27 [24.5, 31.7] years; range, 20.0 to 45.7 years). Subjects in the
longitudinal study had anorexia nervosa for a median of 13 years
(range, 3 to 17 years) and had amenorrhea for a median of
135 months (range, 34 to 204 months). BMATwas inversely asso-
ciated with BMD, parameters of bone microarchitecture, and
bone strength (Table 2).
Association between blood count parameters and BMAT
BMAT at the vertebra and femur was inversely associated with
WBC and/or RBC counts. In particular, BMAT at the L4 vertebra
was significantly inversely associated with WBC count
(rho = −0.37, p = 0.0003) (Fig. 1A and B). BMAT at the femoral
diaphysis and femoral metaphysis were both significantly and
inversely associated with WBC and RBC counts (Table 3). There
was a trend toward an inverse association between BMAT at
the femoral diaphysis and both hemoglobin and hematocrit
levels (rho =−0.20, p = 0.057 for both). There were no significant
associations between BMAT and platelet count.
When we divided the group based on diagnosis/BMI: anorexia
nervosa (n = 35), normal-weight (n = 28), and overweight/obese
(n = 26), there were no significant associations between BMAT
and any hematologic parameters in the women with anorexia
nervosa or normal-weight women. In the women who were
overweight/obese, in contrast to what was observed in the
group as a whole, there was a significant positive association
between L4 vertebral BMAT and RBC count (rho = 0.43, p = 0.03)
and between BMAT at the femoral metaphysis and WBC count
(rho = 0.46, p = 0.02). There was also a positive association
between BMAT at the femoral metaphysis and platelet count in
this group (R = 0.48, p = 0.01).
Association between blood counts and bone parameters
BMD
There were significant and positive associations between WBC
and RBC counts and BMD at the spine and hip (Table 4). BMD
at the PA spine was significantly associated with RBC count
(rho = 0.32, p = 0.002) and WBC count (rho = 0.45, p < 0.0001).
There were no significant associations between hemoglobin or
hematocrit and BMD. Platelet count was positively associated
with both total hip BMD (R = 0.21, p = 0.04) and femoral neck
BMD (R = 0.21, p = 0.04).
Bone microarchitecture and estimated bone strength
Parameters of bone microarchitecture and estimated bone
strength (stiffness and failure load) at the radius and tibia were
significantly associated with WBC and RBC counts (Table 4).
WBC count was positively associated with estimates of failure
load at the radius (rho = 0.40, p < 0.0001) and tibia (rho = 0.41,
p < 0.0001) (Fig. 2A-D). RBC count was also positively associated
with estimates of failure load at both the radius (rho = 0.26, p =
0.01) and tibia (rho = 0.24, p < 0.03). There were no significant
associations between microarchitecture parameters and hemo-
globin or hematocrit levels. Platelet count was only associated
with trabecular bone volume fraction at the radius (rho = 0.24,
p < 0.03) and trabecular thickness at the radius (rho = 0.22,
p < 0.04).
Association between changes in blood counts and
changes in BMAT
Treatment with transdermal estrogen is associated with changes
in BMAT in both postmenopausal women and premenopausal
women.(15,16) In an exploratory analysis, we measured complete
blood counts at baseline and after 6 months of treatment with
transdermal estrogen in six amenorrheic women with anorexia
nervosa. Changes in BMAT at the femoral diaphysis were signifi-
cantly inversely associated with changes in red blood cell count
over the 6-month study (Fig. 3A and B) and with changes in
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hematocrit level (Fig. 3C and D). There were no significant asso-
ciations between change in WBC count and change in BMAT.
Discussion
In this exploratory analysis, we have shown that BMAT, a compo-
nent of the bone marrow microenvironment, is inversely associ-
ated with RBC and WBC counts in a population of
premenopausal women. Although the function of BMAT is not
known, it is inversely associated with bone parameters and
therefore may have a role in mineral metabolism. We now show
that theremay be an association between BMAT and hematopoi-
etic cells in humans, suggesting a possible role for BMAT in
hematopoiesis.
Although BMAT, a component of the bonemarrowmicroenvi-
ronment, has been associated with low bone density,(6–8) its
function has not been fully described. Paradoxically, in models
of chronic starvation, such as anorexia nervosa, although
subcutaneous and visceral adipose tissue stores are reduced,
levels of BMAT are elevated.(8) Why lipid would be stored in the
marrow while other adipose tissue depots are actively being uti-
lized as an energy source during periods of caloric deprivation is
not known, but understanding this paradox may allow us to bet-
ter understand the function of this fat depot.
Given the inverse association betweenmarrow adiposity and
bone density, BMAT has been hypothesized to be an important
determinant of the low BMD and increased fracture risk
observed in women with anorexia nervosa.(26) BMAT is associ-
ated with decreased bone integrity(27) and BMAT is inversely
associated with finite element analysis–derived estimates of
bone strength both in adolescents with anorexia nervosa(28)
and, as our data here show, also in premenopausal adult
women, but whether BMAT is a causative factor of the
increased fracture risk observed in anorexia nervosa remains
to be determined.
In addition to marrow adipocytes, the bone marrow microen-
vironment also consists of osteoblast and hematopoietic
Table 1. Clinical Characteristics of Participants in Cross-Sectional Study and Baseline Characteristics of Subjects With Anorexia Nervosa in
Longitudinal Study
Characteristic Cross-sectional study participants (n = 89) Longitudinal study participants (n = 6)
Age (years) 27.0 (24.5, 31.7); range, 20–45.7 35.7  3.5 (range, 25.3–45.5)
BMI (kg/m2) 22.1 (17.8, 30.8) 17.1  1.4
BMD
Posterior-anterior spine BMD (g/cm2) 0.955 (0.854, 1.078) 0.808  0.111
Lateral spine BMD (g/cm2) 0.743  0.149 0.628 0.109
Total hip BMD (g/cm2) 0.919  0.170 0.739 0.093
Femoral neck BMD (g/cm2) 0.799  0.159 0.647 0.087
Total body BMD (g/cm2) 1.020  0.097 0.982  0.052
Bone marrow adipose tissue
L4 vertebra (lipid/water) 0.54 (0.40, 0.87) 1.18  0.42
Femoral epiphysis (lipid/water) 7.25  2.90 8.17  2.17
Femoral diaphysis (lipid/water) 4.84 (2.61, 7.09) 7.58  1.71
Femoral metaphysis (lipid/water) 3.18 (2.04, 4.89) 5.77  1.96
Microarchitecture parameters at radius
Trabecular BV/TV (%) 0.128 (0.109, 0.151) 0.108  0.024
Trabecular number (1/mm) 1.91 (1.71, 2.12) 1.67  0.24
Trabecular thickness (mm) 0.066 (0.060, 0.074) 0.061 (0.057, 0.072)
Trabecular separation (mm) 0.452 (0.407, 0.520) 0.546  0.093
Cortical thickness (mm) 0.77  0.18 0.61  0.08
Estimates of bone strength at radius
Stiffness (kN/mm) 71.1  15.8 60.0  2.6
Failure load (kN) 3.6  0.8 2.9  0.2
Microarchitecture parameters at tibia
Trabecular BV/TV (%) 0.142  0.038 0.115  0.028
Trabecular number (1/mm) 1.87  0.42 1.70 (1.49, 1.81)
Trabecular thickness (mm) 0.076  0.013 0.071  0.008
Trabecular separation (mm) 0.458 (0.398, 0.540) 0.510 (0.483, 0.638)
Cortical thickness (mm) 1.17 (0.98, 1.33) 0.97  0.22
Estimates of bone strength at tibia
Stiffness (kN/mm) 200.4  44.9 165.6  23.9
Failure load (kN) 10.1  2.2 8.2  1.3
Hematologic parameters
White blood cell count (×10E3/μL) 5.6 (4.7, 7.1) 4.4  1.0
Red blood cell count (×10E6/μL) 4.30  0.34 4.21  0.42
Hemoglobin (g/dL) 12.9  1.0 13.1  1.0
Hematocrit (%) 38.3  2.7 38.9  3.2
Platelet count (×10E3/μL) 254  60 247  63
Values are mean  SD, or median (interquartile range) when data were not normally distributed. BMD = bone mineral density.
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progenitors. A number of studies in both animal models and
humans have investigated the association between hematopoi-
esis and bone formation. In murine models, osteoblastic cells
have been shown to be potential important regulators of hema-
topoiesis.(1,2) In addition, in human studies, bone loss at the hip
has been associated with an increased risk of anemia(5) and
hemoglobin levels have been positively associated with BMD
measured by pQCT(4) and ultrasound.(29) Anemia has also been
associated with increased fracture risk.(3) Our data demonstrate
that the association between RBC and WBC counts and bone
parameters is also significant and positive in premenopausal
women; both RBC and WBC counts were significantly associated
with BMD as well as parameters of bone microarchitecture and
estimates of bone strength.















Posterior–anterior spine BMD (g/cm2) rho = −0.49; p < 0.0001 NS rho = −0.41; p < 0.0001 rho = −0.60; p < 0.0001
Lateral spine BMD (g/cm2) rho = −0.57; p < 0.0001 NS rho = −0.31; p < 0.004 rho = −0.62; p < 0.0001
Total hip BMD (g/cm2) rho = −0.55; p < 0.0001 NS rho = −0.40; p = 0.0001 rho = −0.63; p < 0.0001
Femoral neck BMD (g/cm2) rho = −0.54; p < 0.0001 NS rho = −0.40; p < 0.0001 rho = −0.63; p < 0.0001
Total body BMD (g/cm2) rho = −0.51; p < 0.0001 NS rho = −0.34; p = 0.001 rho = −0.52; p < 0.0001
Microarchitecture parameters at radius
Trabecular BV/TV (%) rho = −0.42; p < 0.0001 rho = −0.27;
p = 0.01
rho = −0.31; p < 0.004 rho = −0.50; p < 0.0001
Trabecular number (1/mm) rho = −0.30; p = 0.004 NS rho = −0.23; p = 0.03 rho = −0.43; p < 0.0001
Trabecular thickness (mm) rho = −0.32; p = 0.002 rho = −0.23;
p = 0.03
rho = −0.22; p = .04 rho = −0.30; p < 0.005
Trabecular separation (mm) rho = 0.34; p = 0.001 NS rho = 0.27; p = 0.01 rho = 0.47; p < 0.0001
Cortical thickness (mm) rho = −0.45; p < 0.0001 NS rho = −0.35; p = 0.0009 rho = −0.40; p = 0.0001
Estimates of bone strength at radius
Stiffness (kN/mm) rho = −0.40; p < 0.0001 NS NS rho = −0.42; p < 0.0001
Failure load (kN) rho = −0.41; p < 0.0001 NS NS rho = −0.44; p < 0.0001
Microarchitecture parameters at tibia
Trabecular BV/TV (%) rho = −0.33; p < 0.002 NS NS rho = −0.37; p = 0.0003
Trabecular number (1/mm) rho = −0.38; p = 0.0003 NS rho = −0.33; p < 0.002 rho = −0.49; p < 0.0001
Trabecular thickness (mm) NS NS NS NS
Trabecular separation (mm) rho = 0.37; p = 0.0003 NS rho = 0.31; p < 0.003 rho = 0.49; p < 0.0001
Cortical thickness (mm) rho = −0.37; p = 0.0004 NS rho = −0.33; p < 0.002 rho = −0.42; p < 0.0001
Estimates of bone strength at tibia
Stiffness (kN/mm) rho = −0.35; p = 0.0008 NS NS rho = −0.39; p = 0.0002
Failure load (kN) rho = −0.35; p = 0.0008 NS NS rho = −0.39; p = 0.0001
BMD = bone mineral density; BV/TV = bone volume/total volume; NS = not significant.
Fig. 1. There was a significant inverse association between white blood cell count and bone marrow adipose tissue at the L4 vertebra (rho = −0.37,
p = 0.0003) (A). Whenwe performed a sensitivity analysis and excluded the two subjects with L4 BMAT ≥2 lipid/water and the five subjects withWBC count
≥9 × 10E3/μL, the association remained significant (rho = −0.33, p = 0.002). Data are also plotted as ranks (B).
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In contrast, less is known about the association between mar-
row adipocytes and hematopoiesis. In a murine model, skeletal
regions with greater BMAT have been associated with fewer
hematopoietic stem cells and in mice who are irradiated and
receive a bone-marrow transplant, inhibition of adipogenesis
after irradiation is associated with improved bone-marrow
engraftment and increased WBC counts.(10) More recently,
reductions in BMAT in a bariatric surgery mouse model have
been associated with increased granulocyte-colony stimulating
factor which, in turn, leads to increased circulating neutrophils.(9)
Our data now show an inverse association between BMAT and
both RBC and WBC counts in humans. Whether BMAT is a nega-
tive regulator of hematopoiesis(10) or whether it may be utilized
to fuel myelopoiesis(9) in humans remains unknown, and future
studies will be necessary to further explore this association.
Given the known association between BMAT and decreased
bone integrity,(27) whether this association between BMAT and
hematopoietic parameters is a potential mediator in the
association between anemia and increased fracture risk, which
has been shown in some populations to be independent of
BMD,(30) also warrants further study.
Interestingly, when we divided the group by BMI, we
found that the association between BMAT and WBC and
RBC counts in overweight/obese women was opposite to that
observed in the group as a whole. In overweight/obese
women, the relationship between BMAT and WBC/RBC counts
was positive. These data are consistent with prior studies sug-
gesting potential differences in BMAT in women with
anorexia nervosa as compared to those who are normal-
weight or overweight/obese. For example, in overweight/
obese women, BMAT is positively associated with visceral adi-
pose tissue,(31) whereas this association is not observed in
lower-weight women.(14) These data may provide further sup-
port for the concept that BMAT may have a different function
in states of nutrient insufficiency as compared to nutrient
sufficiency.















NS NS NS NS
BMAT at femoral epiphysis
(lipid/water)
NS NS NS NS NS


















NS = not significant.
Table 4. Univariate Associations Between BMD, Bone Microarchitecture, Estimated Bone Strength, and Hematopoietic Parameters
Parameter White blood cell count (×10E3/μL) Red blood cell count (×10E6/μL)
BMD
Posterior–anterior spine BMD (g/cm2) rho = 0.45; p < 0.0001 rho = 0.32; p = 0.002
Lateral spine BMD (g/cm2) rho = 0.52; p < 0.0001 R = 0.29; p = 0.006
Total Hip BMD (g/cm2) rho = 0.49; p < 0.0001 R = 0.30; p = 0.004
Femoral neck BMD (g/cm2) rho = 0.50; p < 0.0001 R = 0.32; p = 0.002
Total body BMD (g/cm2) rho = 0.34; p = 0.001 NS
Radial microarchitecture parameters
Trabecular BV/TV (%) rho = 0.33; p = 0.002 rho = 0.25; p < 0.02
Trabecular number (1/mm) rho = 0.26; p = 0.01 rho = 0.29; p < 0.006
Trabecular thickness (mm) rho = 0.25; p < 0.02 NS
Trabecular separation (mm) rho = −0.29; p < 0.01 rho = −0.29; p < 0.007
Cortical thickness (mm) rho = 0.24; p < 0.03 NS
Estimates of bone strength at radius
Stiffness (kN/mm) rho = 0.39; p = 0.0002 R = 0.25; p = 0.02
Failure load (kN) rho = 0.40; p < 0.0001 R = 0.26; p = 0.01
Microarchitecture parameters at tibia
Trabecular BV/TV (%) rho = 0.31; p = 0.003 R = 0.28; p = 0.007
Trabecular number (1/mm) rho = 0.38; p = 0.0003 R = 0.26; p < 0.02
Trabecular thickness (mm) NS NS
Trabecular separation (mm) rho = −0.37; p = 0.0004 rho = −0.29; p < 0.007
Cortical thickness (mm) rho = 0.24; p = 0.02 NS
Estimates of bone strength at tibia
Stiffness (kN/mm) rho = 0.40; p = 0.0001 R = 0.24; p < 0.03
Failure load (kN) rho = 0.41; p < 0.0001 R = 0.24; p < 0.03
BMD = bone mineral density; BV/TV = bone volume/total volume; NS = not significant.
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Fig. 2. There was a significant positive association betweenwhite blood cell count and failure load, an estimate of bone strength, at the radius (rho = 0.40,
p < 0.0001) (A, with ranks plotted in B), and at the tibia (rho = 0.41, p < 0.0001) (C, with ranks plotted in D).
Fig. 3. There was a significant inverse association between% change in bone marrow adipose tissue at the femoral diaphysis and % change in red blood
cell count (rho =−0.83, p = 0.04) (A, with ranks plotted in B) and% change in hematocrit (rho =−0.83, p = 0.04) (C, with ranks plotted inD) after 6 months of
transdermal estrogen treatment in six women with anorexia nervosa.
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Although a major limitation of our study is its cross-sectional
nature, which does not allow us to make any inferences about
causality, the longitudinal component of our study shows a
strong association between changes in BMAT and changes in
RBC counts over a short-time interval. Importantly, this is a
small, exploratory study and therefore meant to be
hypothesis-generating, given the very small sample size, but
these data suggest that BMAT may potentially be a determi-
nant of RBC count. Estrogen has been shown to increase
hematopoietic stem cell division and therefore it will be impor-
tant to determine in future studies whether this association
between changes in BMAT and changes in RBC count is inde-
pendent of estrogen.(32) An additional limitation is that we
did not have data on specific WBC populations (lymphocytes
and neutrophil counts) and prior human studies have demon-
strated differential findings with respect to the association
between BMD and specific WBC populations.(5) Furthermore,
the univariate associations we observed in this study are prone
to confounding, including potential confounding by inflamma-
tory cytokines. Inflammatory cytokines, specifically interleukin-
6 (IL-6), have been shown to be associated with low hemoglo-
bin levels in frail, elderly adults(33) and IL-6 is also a mediator of
osteoclastogenesis,(34) suggesting a possible link between ane-
mia and decreased BMD. Although our population included
premenopausal women, increased IL-6 levels have been
reported both in women with anorexia nervosa and obese
individuals(35,36) and therefore future studies will be necessary
to further explore the possible association between inflamma-
tory cytokines, BMD, and blood counts in these populations.
In conclusion, in this exploratory study, we show an associa-
tion between BMAT and RBC and WBC counts. Further studies
will therefore be necessary to better understand the complex
relationship between adipocyte, osteoblast, and hematopoietic
precursors in the marrow microenvironment in order to gain
insight into the function of BMAT.
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